Cargando…
Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
Objective This clinical study evaluated the clinical performance of composite resin inlays and onlays over 9 years. Materials and Methods Sixty composite resin inlays and onlays were placed in 32 patients, aged 20 to 60 years, by a single operator using the same clinical procedure. The restoration...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890907/ https://www.ncbi.nlm.nih.gov/pubmed/34749421 http://dx.doi.org/10.1055/s-0041-1735420 |
_version_ | 1784661750944104448 |
---|---|
author | Galiatsatos, Aristidis Galiatsatos, Panagiotis Bergou, Dimitra |
author_facet | Galiatsatos, Aristidis Galiatsatos, Panagiotis Bergou, Dimitra |
author_sort | Galiatsatos, Aristidis |
collection | PubMed |
description | Objective This clinical study evaluated the clinical performance of composite resin inlays and onlays over 9 years. Materials and Methods Sixty composite resin inlays and onlays were placed in 32 patients, aged 20 to 60 years, by a single operator using the same clinical procedure. The restorations were examined for fracture rate; esthetics; and patient acceptance and marginal integrity, including caries, marginal discoloration, tooth integrity, and surface texture. All restorations were evaluated at the time of placement and 3, 6, and 9 years after placement by using the modified U.S. Public Health Service criteria. Results At the 3-year follow-up, an Alpha score was given to 88.4% of restorations, while a Bravo score was given to the remaining 11.6%. There was not any failure. At the 6-year follow-up, the success rate of the restorations was 100% without failure. None of the restorations was scored with Delta (D). An Alpha score was given to 60% of the restorations, a Bravo score was assigned to 35%, and a Charlie score was 5% of the restorations. Overall, the success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. An Alpha score was given to 15% of the restorations, a Bravo score was given to 50%, a Charlie score was assigned to 20%, and a D score was given to 15% of the restorations. Conclusion Indirect resin composite inlays and onlays showed acceptable long-term clinical results. The success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. |
format | Online Article Text |
id | pubmed-8890907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Thieme Medical and Scientific Publishers Private Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-88909072022-03-03 Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study Galiatsatos, Aristidis Galiatsatos, Panagiotis Bergou, Dimitra Eur J Dent Objective This clinical study evaluated the clinical performance of composite resin inlays and onlays over 9 years. Materials and Methods Sixty composite resin inlays and onlays were placed in 32 patients, aged 20 to 60 years, by a single operator using the same clinical procedure. The restorations were examined for fracture rate; esthetics; and patient acceptance and marginal integrity, including caries, marginal discoloration, tooth integrity, and surface texture. All restorations were evaluated at the time of placement and 3, 6, and 9 years after placement by using the modified U.S. Public Health Service criteria. Results At the 3-year follow-up, an Alpha score was given to 88.4% of restorations, while a Bravo score was given to the remaining 11.6%. There was not any failure. At the 6-year follow-up, the success rate of the restorations was 100% without failure. None of the restorations was scored with Delta (D). An Alpha score was given to 60% of the restorations, a Bravo score was assigned to 35%, and a Charlie score was 5% of the restorations. Overall, the success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. An Alpha score was given to 15% of the restorations, a Bravo score was given to 50%, a Charlie score was assigned to 20%, and a D score was given to 15% of the restorations. Conclusion Indirect resin composite inlays and onlays showed acceptable long-term clinical results. The success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. Thieme Medical and Scientific Publishers Private Ltd 2021-11-08 /pmc/articles/PMC8890907/ /pubmed/34749421 http://dx.doi.org/10.1055/s-0041-1735420 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Galiatsatos, Aristidis Galiatsatos, Panagiotis Bergou, Dimitra Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study |
title | Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study |
title_full | Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study |
title_fullStr | Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study |
title_full_unstemmed | Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study |
title_short | Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study |
title_sort | clinical longevity of indirect composite resin inlays and onlays: an up to 9-year prospective study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890907/ https://www.ncbi.nlm.nih.gov/pubmed/34749421 http://dx.doi.org/10.1055/s-0041-1735420 |
work_keys_str_mv | AT galiatsatosaristidis clinicallongevityofindirectcompositeresininlaysandonlaysanupto9yearprospectivestudy AT galiatsatospanagiotis clinicallongevityofindirectcompositeresininlaysandonlaysanupto9yearprospectivestudy AT bergoudimitra clinicallongevityofindirectcompositeresininlaysandonlaysanupto9yearprospectivestudy |